Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03677180 · ClinicalTrials.gov registry record
National Cardiogenic Shock Initiative
A clinical trial of Acute Myocardial Infarction and Cardiogenic Shock, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 406
- Enrollment target
- 20
- Study locations
NCT03677180: Completed study of Acute Myocardial Infarction and Cardiogenic Shock, sponsored by Henry Ford Health System.
NCT03677180 is a study of Acute Myocardial Infarction and Cardiogenic Shock that has completed, run by Henry Ford Health System. The registered enrollment target is 406 participants, below the 1,861-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (78% lower). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03677180, a study of Acute Myocardial Infarction and Cardiogenic Shock, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 406 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study evaluates the use of early mechanical circulatory support in patients presenting with acute myocardial infarction and cardiogenic shock. Patients are treated according to the National Cardiogenic Shock Initiative protocol, which emphasizes early identification of cardiogenic shock and rapid delivery of mechanical circulatory support based on invasive hemodynamics. All patients treated in this manner are enrolled in the National Cardiogenic Shock registry.
Primary Outcome
Number of Participants Who Survived at Discharge
Conditions Studied
Study Locations (20)
California
- Loma Linda University Medical Center - Loma Linda
- Ronald Reagan UCLA Medical Center - Los Angeles
- St. Joseph Hospital Orange - Orange
- Mercy General Hospital - Sacramento
- UCLA Medical Center, Santa Monica - Santa Monica
Florida
- Morton Plant Hospital - Clearwater
- North Florida Regional Medical Center - Gainesville
- Palmetto General Hospital - Hialeah
- Orange Park Medical Center - Jacksonville
Arkansas
- Washington Regional Medical Center - Fayetteville
- Arkansas Heart Hospital - Little Rock
- Northwest Medical Center - Springdale - Springdale
Illinois
- Elmhurst Hospital - Elmhurst
- Edward Hospital - Naperville
Alabama
- UAB Hospital - Birmingham
Colorado
- St. Anthony Hospital - Lakewood
Connecticut
- Stamford Hospital - Stamford
District of Columbia
- George Washington University Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 406 participants |
| Start Date | 2016-05-19 |
| Est. Completion | 2020-12-31 |
What the finished NCT03677180 record still lists
NCT03677180 is an observational study that tracks outcomes without assigning an intervention. The registered 406 participants enrollment target is mid-sized for trials with a published cap, below the 1,861-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (78% lower).
The record links to 5 conditions, with Acute Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.
NCT03677180 names 20 study sites across 10 states, led by California, Florida, Arkansas.
Frequently Asked Questions
What is clinical trial NCT03677180 about?
NCT03677180 is a clinical study titled "National Cardiogenic Shock Initiative". This study evaluates the use of early mechanical circulatory support in patients presenting with acute myocardial infarction and cardiogenic shock. Patients are treated according to the National Cardiogenic Shock Initiative protocol, which emphasizes early identification of cardiogenic shock and rap...
What is the current status of trial NCT03677180?
This trial is currently completed. The enrollment target is 406 participants. The study started on 2016-05-19. Estimated completion is 2020-12-31.
What conditions does trial NCT03677180 study?
This clinical trial studies the following conditions: Acute Myocardial Infarction, Cardiogenic Shock, NSTEMI - Non-ST Segment Elevation MI, Heart Attack, STEMI - ST Elevation Myocardial Infarction.
Who is sponsoring clinical trial NCT03677180?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03677180 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03677180's enrollment target sits among peer trials
406 12th of 19 higher than 8 of 19 other Acute Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
RECRUITING · NA
-
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
RECRUITING
-
Abbott Vascular Medical Device Registry
RECRUITING
-
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
RECRUITING · NA
-
Arrhythmia Detection After MI
RECRUITING · NA
-
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06223360 · 406 participants · Phase 2
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- NCT06411769 · 406 participants · NA
Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas
- NCT06585787 · 406 participants · Phase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- NCT06735534 · 407 participants · NA
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI